Why the study?
The study was conducted to determine whether fecal calprotectin could be useful in predicting the development or persistence of coronary artery lesions in Kawasaki disease.
Does the combination of fecal calprotectin > 250 microg/g and initial coronary dimension z-score > 2 predict the persistence of coronary artery lesions in children with Kawasaki Disease?
Does the combination of fecal calprotectin > 250 microg/g and initial coronary dimension z-score > 2 predict the persistence of coronary artery lesions in children with Kawasaki Disease?
The combination of fecal calprotectin > 250 microg/g and an initial coronary z-score > 2 during the acute phase of Kawasaki Disease may serve as a useful predictor for the persistence of coronary artery lesions, particularly in children with initial CRP < 13 mg/dL.
Answers are grounded in this paper and cite their sources.
May help stratify persistent coronary risk in Kawasaki disease; leaves open whether this combination improves prediction or warrants targeted therapy.
Kawasaki Disease (KD) is systemic vasculitis involving medium-sized vessels in children. The aim of our study is to determine if fecal calprotectin (FC) could be useful in predicting the development or persistence of coronary artery lesions (CALs) in KD. We conducted a prospective monocentric study including all consecutive diagnoses of. Clinical, laboratory, echocardiographic data were recorded during the acute and subacute phase, including FC. Correlations among laboratory values, FC, clinical manifestations, IVIG-responsiveness and CALs development were investigated. We enrolled 26 children (76.9% boys; median age 34.5 months). The combination of FC > 250 microg/g and z-score > 2 during the acute phase was associated with the persistence of CALs (p = 0.022). A z-score > 2 alone during the acute phase was not related to CALs during the subacute stage (p > 0.05). A neutrophil percentage > 70% and WBC > 15,000/mmc during the acute phase significantly correlated with the presence of CALs during the subacute phase (p = 0.008). C-reactive protein (CRP) > 13 mg/dL at KD onset was significantly associated with the presence of CALs during the acute (p = 0.017) and subacute phase (p = 0.001). The combination of FC > 250 microg/g and a z-score > 2 during the acute phase of KD may be used as a predictor of CALs persistence. It can be useful especially in children with an initial CRP < 13 mg/dl.
No takes yet. Share an insight, caveat, or question.
Fabi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: